Peripheral Blood Mononuclear Cell ABCA1 Transcripts and Protein Expression in Acute Myocardial Infarction

Area of Science:

• Cardiovascular Research
• Molecular Biology
• Metabolic Diseases

Background:

• ATP binding cassette transporter-A1 (ABCA1) is crucial for high-density lipoprotein (HDL) formation.
• HDL offers protection against atherothrombosis and myocardial infarction (MI) due to its anti-atherosclerotic properties.
• Investigating PBMNC ABCA1 expression in MI is essential for understanding cardiovascular disease mechanisms.

Purpose of the Study:

• To examine the role of peripheral blood mononuclear cell (PBMNC) ABCA1 expression in patients with acute myocardial infarction (AMI).
• To compare PBMNC ABCA1 levels between AMI patients (with and without type 2 diabetes) and healthy controls.

Main Methods:

• Quantitative real-time polymerase chain reaction (qRTPCR) was used to analyze PBMNC ABCA1 mRNA transcripts.
• Enzyme-linked immunosorbent assay (ELISA) was employed to measure PBMNC ABCA1 protein levels.
• Participants included 29 males with AMI and 20 healthy controls, with subgrouping for type 2 diabetes (T2DM).

Main Results:

• No significant differences in PBMNC ABCA1 mRNA or protein levels were found in AMI patients compared to controls.
• ABCA1 protein positively correlated with HDL-cholesterol in AMI patients with T2DM (r = 0.655, p = 0.021).
• ABCA1 protein negatively correlated with age in AMI patients without T2DM (r = -0.525, p = 0.031) and was associated with smoking and alcohol habits.

Conclusions:

• Metabolites of diabetes and ischemia influence PBMNC ABCA1 protein and HDL-C levels in AMI patients.
• Cardiovascular risk factors like smoking and alcohol consumption warrant further investigation in larger cohorts.
• Managing these risk factors may enhance PBMNC ABCA1 protein stability and improve HDL-C levels.